Prospective Study of Treatment Pattern, Effectiveness, and Safety of Zoledronic Acid (ZOL) Therapy Beyond 24 Months in Patients (PTS) with Multiple Myeloma (MM) or Solid Tumor Bone Metastasis (STM) | Publicación